Search research articles
Contact Us
Filters
Showing results (261-270 of 279) with videos related to
Page
of 28
Sort By:
Clinical Hypertension
|
September 8, 2017
Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial
Gyu Chul Oh, Hae-Young Lee, Wook Jin Chung, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
August 21, 2023
Home blood pressure-centered approach - from digital health to medical practice: HOPE Asia Network consensus statement 2023
Kazuomi Kario, Naoko Tomitani, Tzung-Dau Wang, et al.
Drug Design, Development and Therapy
|
May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III Study
Jong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.
Clinical Therapeutics
|
September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension
Hae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.
Clinical Therapeutics
|
December 16, 2025
Corrigendum to "Multicenter, Randomized, Double-Blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension" (Clin Ther. 2025 Oct 28. [Epub ahead of print])
Jinho Shin, Seong Hwan Kim, Ki Hoon Han, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCT
Jeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
Clinical Therapeutics
|
August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy
Kwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.
Trials
|
July 3, 2019
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial
Min-Gu Kang, Kwang-Il Kim, Sang Hyun Ihm, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
August 24, 2023
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial
Eun Joo Cho, Moo Hyun Kim, Young-Hak Kim, et al.
Journal of Clinical Medicine
|
March 6, 2021
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study
In-Jeong Cho, Jeong-Hun Shin, Mi-Hyang Jung, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 279) with videos related to
Sort By:
Page
of 28
Clinical Hypertension
|
September 8, 2017
Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial
Gyu Chul Oh, Hae-Young Lee, Wook Jin Chung, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
August 21, 2023
Home blood pressure-centered approach - from digital health to medical practice: HOPE Asia Network consensus statement 2023
Kazuomi Kario, Naoko Tomitani, Tzung-Dau Wang, et al.
Drug Design, Development and Therapy
|
May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III Study
Jong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.
Clinical Therapeutics
|
September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension
Hae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.
Clinical Therapeutics
|
December 16, 2025
Corrigendum to "Multicenter, Randomized, Double-Blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension" (Clin Ther. 2025 Oct 28. [Epub ahead of print])
Jinho Shin, Seong Hwan Kim, Ki Hoon Han, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCT
Jeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
Clinical Therapeutics
|
August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy
Kwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.
Trials
|
July 3, 2019
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial
Min-Gu Kang, Kwang-Il Kim, Sang Hyun Ihm, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
August 24, 2023
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial
Eun Joo Cho, Moo Hyun Kim, Young-Hak Kim, et al.
Journal of Clinical Medicine
|
March 6, 2021
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study
In-Jeong Cho, Jeong-Hun Shin, Mi-Hyang Jung, et al.
Page
of 28